Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development
Objective: to assess the relevance and commercial prospects of bringing to market a drug for the local treatment of infectious and inflammatory diseases of oral cavity and oropharynx.Material and methods. The objects of the study were the drug nomenclatures in the State Register of Medicines, the Re...
Saved in:
Main Authors: | V. I. Zvereva (Author), D. R. Dzhavakhyan (Author), V. N. Dul (Author), V. S. Bobyleva (Author), A. A. Markaryan (Author), E. I. Morkovin (Author), D. V. Kurkin (Author), M. A. Dzhavakhyan (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overview of drugs approved by the FDA in 2022
by: D. V. Kurkin, et al.
Published: (2023) -
Purulent-inflammatory manifestations in the oropharynx in children with infectious mononucleosis
by: L. N. Tuychiev, et al.
Published: (2024) -
<i>In-vitro</i> dissolution profiles comparison for various drugs with active ingredient Febuxostat commercially available on the Russian market
by: S. V. Denkina, et al.
Published: (2024) -
Higher prevalence and gene amplification of HPV16 in oropharynx as compared to oral cavity
by: Hideo SHIGEISHI, et al. -
Oropharynx Ulceration
by: Lauren Sylwanowicz, et al.
Published: (2017)